Fundamentals of cancer metabolism
Open accessThe DOI matches its Crossref record; 203 of the 204 references it cites were found in a registry or an index.
Abstract
Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IDH1/2 mutations have been identified in a range of tumor types, including solid tumors (e.g., gliomas and chondrosarcomas) and blood cancers like acute myelogenous leukemia (169, 170, 171).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we propose that pharmacological ascorbate can potentially circumvent this problem by exploring two common features of cancer cells: their increased levels of labile transition metals, especially iron21, and their increased reliance on glucose uptake and glycolysis22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, certain cancer cells may use carbon sources such as glutamine or acetate to compensate for the reduction in acetyl-CoA synthesis from glucose [94,95].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased aerobic glycolysis is frequently observed in BAP1+/− cells [141], also analyzing the plasmatic metabolic profiles of individuals carrying different germline BAP1 mutations in comparison to BAP1 wild-type (BAP1WT) controls derived from two families [140].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [141]
Experimental — accuracy not yet measuredIn the citing paper
“Tumour cells exhibit a high rate of glycolysis, even in conditions with ample oxygen — a phenomenon that was first described by Otto Warburg, nearly a century ago22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 21×
“When tumor cells become nutrient-deprived, they adapt to the microenvironment by decreasing their demand for ATP.”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“mTORC1 is stimulated by the presence of amino acids and activates protein synthesis via its effects on translation and ribosome biogenesis (80).”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“ROS are intracellular chemical species that contain oxygen and include the superoxide anion (O2 ), hydrogen peroxide (H2O2), and the hydroxyl radical (OH·) (114).”
BackgroundThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Themetabolic adaptation to hypoxia is coordinated by HIF-1, which induces metabolic genes involved in increasing glycolytic flux (23).”
Background
Cited by
Items 501–600 of 1,007
Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma
Capece, D., D’Andrea, D., Begalli, F., Goracci, L., Tornatore, L., Alexander, J. L., Veroli, A. D., Leow, S. C., Vaiyapuri, T. S., Ellis, J. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137845 · Cited by 65
“However, translating oncological metabolic targets to the clinical setting has been complicated by the frequent toxicities produced by the suppression of mechanisms that are also required for normal cell function (59, 60).”
BackgroundSang, R., Fan, R., Deng, A., Gou, J., Lin, R., Zhao, T., Hai, Y., Song, J., Liu, Y., Qi, B., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00118 · Cited by 62
Aging, Metabolism, and Cancer Development: from Peto’s Paradox to the Warburg Effect
Tidwell, T., Søreide, K., & Hagland, H. R. (2017) · Aging and Disease · doi:10.14336/ad.2017.0713 · Cited by 70
“The last decade of scientific research has dramatically improved our understanding of the aging process and that it is closely regulated by key metabolic proteins such as mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), and insulin/insulin growth factor (IGF) [7, 8], which are associated wi…”
BackgroundArginine: Challenges and opportunities of this two-faced molecule in cancer therapy
Jahani, M., Noroznezhad, F., & Mansouri, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.109 · Cited by 64
SIRT1 in the Development and Treatment of Hepatocellular Carcinoma
Farcas, M. F., Andrei-Alexandru, G., Gulei, D., Ionescu, C., Irimie, A., Cătană, C.-S., & Berindan‐Neagoe, I. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00148 · Cited by 64
“Metabolic reprogramming is a hallmark of cancer and plays a vital role in cancer progression (96); however, the regulator of metabolic reprogramming that drives the switch from oxidative phosphorylation to aerobic glycolysis in LCSC is not fully understood.”
BackgroundTargeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
Gatzka, M. (2018) · Cancers · doi:10.3390/cancers10060155 · Cited by 61
“On the one hand, oncogenic signaling pathways, such as the MAPK pathway, regulate the use of glucose and amino acids and the switch from oxidative phosphorylation (oxphos) to anaerobic glycolysis (known as “Warburg effect”) in tumor cells (reviewed in [71]).”
BackgroundThe Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
Tanabe, A., & Sahara, H. (2020) · Cancers · doi:10.3390/cancers12102780 · Cited by 65
“The main fuel of the TCA cycle is acetyl-CoA that is derived from glucose, but when there are insufficient amounts of available glucose or under conditions of hypoxia, glutamine, other branched-chain amino acids, and acetyl-CoA produced by the β-oxidation of fatty acids are used as fuel in the TCA cycle [28,37,54].”
BackgroundKocher, F., Amann, A., Zimmer, K., Geisler, S., Fuchs, D., Pichler, R., Wolf, D. G. F., Kurz, K., Seeber, A., & Pircher, A. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-380 · Cited by 65
“However, in addition to genetic alterations, cancer cells have to undergo adaptive metabolic reprogramming to enable adequate nutritional supply and to counterbalance hypoxic stress of the tumor microenvironment (TME) to ensure their survival (6-13).”
BackgroundSREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer
Jin, Y., Chen, Z., Dong, J., Wang, B., Fan, S., Yang, X., & Cui, M. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13137 · Cited by 65
Contribution of the Clp Protease to Bacterial Survival and Mitochondrial Homoeostasis
Illigmann, A., Thoma, Y., Pan, S., Reinhardt, L., & Brötz‐Oesterhelt, H. (2021) · Microbial Physiology · doi:10.1159/000517718 · Cited by 65
“…that, despite their heavy fermentation, most tumours still rely on mitochondrial OXPHOS for ATP generation and that mitochondria serve multiple central functions in tumour cell progression, including protein homoeostasis and quality control [DeBerardinis and Chandel, 2016; Zong et al., 2016].”
BackgroundCell line-directed breast cancer research based on glucose metabolism status
Farhadi, P., Yarani, R., Valipour, E., Kiani, S., Hoseinkhani, Z., & Mansouri, K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112526 · Cited by 62
Gut microbial metabolites and its impact on human health
Rahman, S., O'Connor, A. L., Becker, S. L., Patel, R. K., Martindale, R. G., & Tsikitis, V. L. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0809 · Cited by 105
“Increased plasma levels of BCAAs are also found in both pancreatic and breast cancers [83,87].”
Yan, P., Liu, J., Li, Z., Wang, J., Zhu, Z., Wang, L., & Yu, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010315 · Cited by 73
Mendoza, E. N., Ciriolo, M. R., & Ciccarone, F. (2025) · Antioxidants · doi:10.3390/antiox14010094 · Cited by 74
“…to survive and proliferate despite oxidative stress caused by hypoxia and ROS mainly rely on the stabilization of HIF transcription factors, which trigger survival pathways, support blood vessel growth, and increase glycolysis, redirecting metabolism from processes that depend on oxygen [3,8,14].”
Singh, L., Aldossary, S. A., Saeedan, A. S., Ansari, M. N., & Kaithwas, G. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.016 · Cited by 63
Polyamine pathway activity promotes cysteine essentiality in cancer cells
Zhang, T., Bauer, C., Newman, A. C., Uribe, A. H., Athineos, D., Blyth, K., & Maddocks, O. D. K. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0253-2 · Cited by 59
Wei, W.-S., Wang, N., Deng, M.-H., Dong, P., Liu, J., Xiang, Z., Li, X., Li, Z., Liu, Z., Peng, Y., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102201 · Cited by 58
“It is known that ROS can serve as signaling molecules to promote cell growth at low or moderate levels but high levels of ROS can induce cell apoptosis [36].”
BackgroundKim, H., Park, H., Chang, H. W., Back, J. H., Lee, S. J., Park, Y. E., Kim, E. H., Hong, Y., Kwak, G., Kwon, I. C., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.021 · Cited by 75
Parma, B., Wurdak, H., & Ceppi, P. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100888 · Cited by 64
“cancer cells undergo metabolic rewiring or reprogramming (DeBerardinis and Chandel, 2016).”
BackgroundZhang, X., Zhao, Q. C., Yang, J., Wang, T., Chen, F., & Zhang, K. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215115 · Cited by 60
Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance
Steinbuch, S. C., Lüß, A.-M., Eltrop, S., Götte, M., & Kiesel, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084306 · Cited by 80
Zhao, S., Zhang, X., Chen, S., & Zhang, S. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01700-0 · Cited by 64
Metabolic reprogramming as a feast for virus replication
Polčicová, K., Baďurová, L., & Tomášková, J. (2020) · Acta Virologica · doi:10.4149/av_2020_210 · Cited by 60
Wilcock, D. J., Badrock, A. P., Wong, C. W., Owen, R., Guerin, M., Southam, A. D., Johnston, H., Telfer, B. A., Fullwood, P., Watson, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110995 · Cited by 57
Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy
Chen, C., Wang, Z., & Qin, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935536 · Cited by 75
“Such changes facilitate the accumulation of metabolites that ultimately lead to epigenetic dysfunction (DeBerardinis and Chandel, 2016) and immunosuppression (Table 3).”
BackgroundUnveiling the future: Breakthroughs and innovations in MXene-based electrochemical sensors
Khan, M. U. A., Sun, X., Attique, F., Saleh, M. T., Ahmad, N., Atiq, K., Shafi, M., Ahmed, I. A., Barsoum, I., Rafique, M. S., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.160392 · Cited by 63
Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
Sellers, K., Allen, T. D., Bousamra, M., Tan, J., Méndez‐Lucas, A., Lin, W., Bah, N. K., Chernyavskaya, Y., MacRae, J. I., Higashi, R. M., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0464-z · Cited by 58
“Tumour metabolism is an emerging source of novel targets, as cancers alter their metabolism in order to facilitate proliferation, migration and survival in the tumour microenvironment.(7) The notion that altered metabolism is a hallmark of tumorigenesis(8) is underscored by the discovery that driver oncogenes and tumo…”
BackgroundSubgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
Park, A. K., Lee, J. Y., Cheong, H., Ramaswamy, V., Park, S., Kool, M., Phi, J. H., Choi, S. A., Cavalli, F. M. G., Taylor, M. D., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5742-x · Cited by 73
Redox Signaling from Mitochondria: Signal Propagation and Its Targets
Ježek, P., Holendová, B., & Plecitá‐Hlavatá, L. (2020) · Biomolecules · doi:10.3390/biom10010093 · Cited by 62
“MitoROS = redox signaling/hypoxia PHD/HIF-mediated transcriptome reprogramming [19] [20] [21] MitoROS - PHD-HIF - Warburg phenotype Oncogenes 2hydroxyglutarate- altered epigenetics Cancer [2,8,22] [23,24] [25]”
BackgroundKhan, S., Ince-Dunn, G., Suomalainen, A., & Elo, L. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129202 · Cited by 63
“Furthermore, secondary mitochondrial diseases include, for instance, neurodegenerative disorders, such as Parkinson’s disease, and mitochondrial metabolism also may contribute to cancer progression (14).”
BackgroundNitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer
Mishra, D., Patel, V., & Banerjee, D. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223419882688 · Cited by 73
Sarfraz, I., Rasul, A., Hussain, G., Shah, M. A., Zahoor, A. F., Asrar, M., Selamoğlu, Z., Ji, X., Adem, Ş., & Sarker, S. D. (2020) · BioFactors · doi:10.1002/biof.1624 · Cited by 60
Metabolic Control of m6A RNA Modification
Kim, J., & Lee, G. (2021) · Metabolites · doi:10.3390/metabo11020080 · Cited by 62
Sviderskiy, V. O., Blumenberg, L., Gorodetsky, E., Karakousi, T. R., Hirsh, N., Alvarez, S. W., Terzi, E. M., Kaparos, E., Whiten, G. C., Ssebyala, S., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.016 · Cited by 56
“Several studies have also demonstrated that inhibition of reprogrammed pathways or deprivation of tumor-essential nutrients can suppress tumor growth (Birsoy et al., 2014; DeBerardinis and Chandel, 2016; Rimawi et al., 2015).”
BackgroundChen, Y., Li, Y., Huang, L., Du, Y., Gan, F., Li, Y., & Yao, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6620306 · Cited by 68
“Tumour cells reprogramme metabolism to meet the need of malignant proliferation and metastasis [125].”
BackgroundMetabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
Hvinden, I. C., Cadoux-Hudson, T. A. D., Schofield, C. J., & McCullagh, J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100469 · Cited by 71
“Metabolic alterations are a hallmark of cancer, but their role in tumorigenesis is not well understood.(1,2) Mutations in the genes encoding enzymes linked to central carbon metabolism have been found in some cancers, including enzymes such as isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH),(3) and fumar…”
BackgroundStructural and Functional Insights into GID/CTLH E3 Ligase Complexes
Maitland, M. E. R., Lajoie, G., Shaw, G. S., & Schild‐Poulter, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115863 · Cited by 59
Sun, J., Ding, J., Yue, H., Xu, B., Sodhi, A., Xue, K., Ren, H., & Qian, J. (2024) · Autophagy · doi:10.1080/15548627.2024.2395142 · Cited by 61
“Tumor cells flexibly adjust energy metabolism to adapt to different survival pressures of a changing tumor microenvironment [40,41].”
Metabolism and epigenetics of pancreatic cancer stem cells
Lanfranca, M. P., Thompson, J. K., Bednar, F., Halbrook, C. J., Lyssiotis, C. A., Lévi, B., & Frankel, T. L. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.008 · Cited by 60
“Metabolic reprograming was recognized several decades ago as one of the hallmarks of cancer cells [53, 54].”
BackgroundLoss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
Lee, J., Lee, H., Lee, S., Kang, J. H., Lee, S.-H., Kim, S., Cho, E. S., Kim, N. H., Yook, J. I., & Kim, S. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.036 · Cited by 59
“However, the respiratory rates of cancer cells are as high as those of normal cells [2,3].”
BackgroundExtracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity
Lucchetti, D., Tenore, C. R., Colella, F., & Sgambato, A. (2020) · Cancers · doi:10.3390/cancers12010171 · Cited by 62
“In the meantime, the TCA cycle is also replenished by an increased consumption of glutamine [10,11].”
BackgroundYap/Taz promote the scavenging of extracellular nutrients through macropinocytosis
King, B., Araki, J., Palm, W., & Thompson, C. B. (2020) · Genes & Development · doi:10.1101/gad.340661.120 · Cited by 62
“Anabolic growth is the process by which cells convert sources of reduced carbon and nitrogen to higher order structures, such as lipids, proteins and nucleotides, to build the biomass that supports proliferation (DeBerardinis and Chandel 2016).”
BackgroundYu, H., Yin, Y., Yi, Y., Cheng, Z., Kuang, W., Li, R., Zhong, H., Cui, Y., Yuan, L., Gong, F., et al. (2020) · 癌症:英文版 · doi:10.1002/cac2.12080 · Cited by 60
Vitamin C Intake and Cancers: An Umbrella Review
Chen, Z., Huang, Y. C., Cao, D., Qiu, S., Chen, B., Li, J., Bao, Y., Wei, Q., Han, P., & Liu, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.812394 · Cited by 242
“However, excessive ROS level could lead to cell death (64).”
BackgroundAlseksek, R. K., Ramadan, W. S. H., Saleh, E., & El‐Awady, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158141 · Cited by 66
Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer
Lanzetti, L. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01402-6 · Cited by 65
“A detailed description of these mechanisms is beyond the scope of this review; thus, the reader is referred to excellent reviews on the subject [10, 11].”
Paradoxical roles of dual oxidases in cancer biology
Little, A. C., Sulovari, A., Danyal, K., Heppner, D. E., Seward, D. J., & van der Vliet, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.05.024 · Cited by 56
“Indeed, cancer cells are typically characterized by elevated amounts of ROS, and various lines of evidence indicate their ability to contribute to cancer progression[9, 10, 12].”
BackgroundArif, T., Paul, A., Krelin, Y., Shteinfer‐Kuzmine, A., & Shoshan‐Barmatz, V. (2018) · Cancers · doi:10.3390/cancers10120499 · Cited by 58
“Respiration, oxidative metabolism, and other mitochondrial activities are also required by cancer cells for tumour growth [4,7].”
Genovese, S., Clément, R., Gaultier, C., Besse, F., Narbonne-Reveau, K., Daian, F., Foppolo, S., Luis, N. M., & Maurange, C. (2019) · eLife · doi:10.7554/elife.50375 · Cited by 58
Fakhri, S., Khodamorady, M., Naseri, M., Farzaei, M. H., & Khan, H. Z. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104895 · Cited by 62
Metabolism of Innate Immune Cells in Cancer
Talty, R., & Olino, K. L. (2021) · Cancers · doi:10.3390/cancers13040904 · Cited by 60
Qin, S., Mao, Y., Wang, H., Duan, Y., & Zhao, L. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.60641 · Cited by 61
“bioenergy, biosynthesis, and redox requirements [61].”
PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells
Bluemel, G., Planque, M., Madreiter‐Sokolowski, C. T., Haitzmann, T., Hrzenjak, A., Graier, W. F., Fendt, S., Olschewski, H., & Leithner, K. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.007 · Cited by 58
Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux
Jones, B. C., Pohlmann, P. R., Clarke, R. C., & Sengupta, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10027-5 · Cited by 60
“Elevated glycolysis not only provides energy but also ensures that the high demands of anabolic processes are met to support the often rapid growth of tumor cells [4].”
BackgroundLee, I., Kim, S.-H., Rethinasabapathy, M., Haldorai, Y., Lee, G.-W., Choe, S. R., Jang, S.-C., Kang, S., Han, Y., Roh, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22715-w · Cited by 54
Carmona, M., de Cubas, L., Bautista, È., Moral-Blanch, M., Medraño-Fernández, I., Sitia, R., Boronat, S., Ayté, J., & Hidalgo, E. (2019) · Nature Communications · doi:10.1038/s41467-019-12475-0 · Cited by 60
SIRT3-Mediated SOD2 and PGC-1α Contribute to Chemoresistance in Colorectal Cancer Cells
Paku, M., Haraguchi, N., Takeda, M., Fujino, S., Ogino, T., Takahashi, H., Miyoshi, N., Uemura, M., Mizushima, T., Yamamoto, H., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09373-x · Cited by 55
Nakasuka, F., Tabata, S., Sakamoto, T., Hirayama, A., Ebi, H., Yamada, T., Umetsu, K., Ohishi, M., Ueno, A., Goto, H., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02323-7 · Cited by 62
Torrence, M. E., & Manning, B. D. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050329 · Cited by 60
“Cell proliferation, both normal and neoplastic, requires the production of biomass in the form of proteins, nucleic acids, and lipids from available nutrients and energy, and cancer cells display an enhanced capacity to produce these macromolecular building blocks (DeBerardinis & Chandel 2016).”
BackgroundTargeting the Redox Landscape in Cancer Therapy
Narayanan, D., Ma, S., & Özcelik, D. (2020) · Cancers · doi:10.3390/cancers12071706 · Cited by 61
“Hypoxic conditions stimulate remodeling of the tissue microenvironment in order to ensure influx of nutrition, efflux of waste products, and establishment of a suitable redox microenvironment [12].”
BackgroundEndogenous toxic metabolites and implications in cancer therapy
Lee, N., Spears, M. E., Carlisle, A. E., & Kim, D. (2020) · Oncogene · doi:10.1038/s41388-020-01395-9 · Cited by 58
Nie, H., Huang, P.-Q., Jiang, S.-H., Yang, Q., Hu, L.-P., Yang, X., Li, J., Wang, Y., Li, Q., Zhang, Y., et al. (2021) · Theranostics · doi:10.7150/thno.51712 · Cited by 54
“Cancer cells frequently have metabolic alterations that endow them with proliferative advantages [50, 51].”
Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy
Leone, R. D., & Powell, J. D. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0791 · Cited by 56
“In order to support the tremendous growth that characterizes tumors, cancer cells engage unique metabolic programs (1).”
BackgroundExpanding Roles of De Novo Lipogenesis in Breast Cancer
Simeone, P., Tacconi, S., Longo, S., Lanuti, P., Bravaccini, S., Pirini, F., Ravaioli, S., Dini, L., & Giudetti, A. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073575 · Cited by 58
Li, J., Hu, Z.-E., We, Y.-J., Liu, Y., Wang, N., & Yu, X. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.08.114 · Cited by 53
Targeting mitochondrial metabolism for metastatic cancer therapy
Passaniti, A., Kim, M. S., Polster, B. M., & Shapiro, P. S. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23436 · Cited by 65
“been shown to inhibit glucose uptake, OxPhos, and also anaerobic (glycolytic) metabolism that support a metastatic phenotype.(24,37,38) A major regulator of mitochondrial respiration, or oxygen consumption”
BackgroundRácz, B., & Spengler, G. (2023) · Antibiotics · doi:10.3390/antibiotics12010137 · Cited by 64
The Role of Reprogrammed Glucose Metabolism in Cancer
Ediriweera, M. K., & Jayasena, S. (2023) · Metabolites · doi:10.3390/metabo13030345 · Cited by 62
Abdelmaksoud, N. M., Abulsoud, A. I., Abdelghany, T. M., Elshaer, S. S., Rizk, S. M., & Senousy, M. A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154509 · Cited by 58
Complex II ambiguities—FADH2 in the electron transfer system
Gnaiger, E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105470 · Cited by 62
“In cancer tissues, CII plays a key role in metabolic remodeling (23, 24).”
BackgroundCelestini, V., Tezil, T., Russo, L., Fasano, C., Sanese, P., Forte, G., Peserico, A., Signorile, M. L., Longo, G., Rasmo, D. D., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0336-0 · Cited by 60
Shao, J., Pijpers, I. A. B., Cao, S., Williams, D. S., Yan, X., Li, J., Abdelmohsen, L. K. E. A., & van Hest, J. C. M. (2019) · Advanced Science · doi:10.1002/advs.201801678 · Cited by 54
LIPG‐promoted lipid storage mediates adaptation to oxidative stress in breast cancer
Cadenas, C., Vosbeck, S., Edlund, K., Grgas, K., Madjar, K., Hellwig, B., Adawy, A., Glotzbach, A., Stewart, J. D., Lesjak, M. S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32138 · Cited by 58
“Although cancer cells have generally high ROS levels, these levels further increase under a harsh tumour microenvironment, nutrient deprivation or upon matrix detachment.(40,41) Thus, metabolic adaptation to these conditions via LIPG upregulation may be a crucial event determining adverse progression, as suggested by…”
BackgroundLactate dehydrogenase B regulates macrophage metabolism in the tumor microenvironment
Frank, A.-C., Raue, R., Fuhrmann, D. C., Sirait‐Fischer, E., Reuse, C., Weigert, A., Lütjohann, D., Hiller, K., Syed, S. N., & Brüne, B. (2021) · Theranostics · doi:10.7150/thno.58380 · Cited by 60
“Aerobic glucose metabolisms, besides glutamine consumption, are of major importance to harness energy for tumor growth [1, 2].”
BackgroundIdentification and prognostic value of metabolism-related genes in gastric cancer
Wen, F., Huang, J., Lu, X., Huang, W., Wang, Y., Bai, Y., Ruan, S., Gu, S., Chen, X., & Shu, P. (2020) · Aging · doi:10.18632/aging.103838 · Cited by 53
“confirmed that glycolysis is correlated with activated oncogenes and mutated tumor suppressors [11].”
BackgroundCholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
de Gauna, M. R., Biancaniello, F., González‐Romero, F., Rodrigues, P. M., Lapitz, A., Gómez‐Santos, B., Olaizola, P., Matteo, S. D., Aurrekoetxea, I., Labiano, I., et al. (2022) · Hepatology · doi:10.1002/hep.32344 · Cited by 54
“[11] The cancer- specific metabolic adaptability also contributes to the spread and survival to treatments.[11] Thus, there is a need to identify specific metabolic rewiring of each cancer type.”
BackgroundInfluentialChen, X., Liu, L., Kang, S., Gnanaprakasam, J. R., & Wang, R. (2023) · Science Advances · doi:10.1126/sciadv.add9554 · Cited by 57
“The LDH activity not only is indispensable for sustaining glycolytic flux but also is critical for controlling the ratio of free cytosolic [NAD + ]/[NADH], which reflects the overall redox state in hyperproliferating cells such as active T cells and cancer cells ( 19 , 20 , 34 – 37 ).”
Influenza A virus-induced glycolysis facilitates virus replication by activating ROS/HIF-1α pathway
Zhang, Y., Chang, L., Xin, X., Qiao, Y., Qiao, W., Ping, J., Xia, J., & Su, J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.10.304 · Cited by 56
Meijer, T. W. H., Peeters, W. J. M., Dubois, L. J., van Gisbergen, M. W., Biemans, R., Venhuizen, J., Span, P. N., & Bussink, J. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.10.016 · Cited by 57
Ning, B., Yu, D., & Yu, A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113638 · Cited by 54
Hu, S., Sechi, M., Singh, P. K., Dai, L., McCann, S., Sun, D., Ljungman, M. E., & Neamati, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01016 · Cited by 55
“5,8-Dimethoxy-7-methylquinazoline [9]—Zinc powder (15 eq.”
Mozolewska, P., Duzowska, K., Pakiet, A., Mika, A., & Śledziński, T. (2020) · Anticancer Research · doi:10.21873/anticanres.14487 · Cited by 57
ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses
Kaymak, I., Watson, M. J., Oswald, B. M., Ma, S., Johnson, B. K., DeCamp, L. M., Mabvakure, B. M., Luda, K. M., Ma, E. H., Lau, K. H., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231820 · Cited by 63
“…coordinating cellular metabolic activity is the mitochondrion, which supports cellular bioenergetics via oxidative phosphorylation (OXPHOS) and synthesis of biosynthetic intermediates via the tricarboxylic acid (TCA) cycle (Mehta et al., 2017; Steinert et al., 2021; DeBerardinis and Chandel, 2016).”
Acidosis orchestrates adaptations of energy metabolism in tumors
Groessl, S., Kalis, R., Snaebjornsson, M. T., Wambach, L., Haider, J., Andersch, F., Schulze, A., Palm, W., & Zuber, J. A. (2025) · Science · doi:10.1126/science.adp7603 · Cited by 67
Hardeman, K. N., Peng, C., Paudel, B. B., Meyer, C. T., Luong, T., Tyson, D. R., Young, J. D., Quaranta, V., & Fessel, J. P. (2017) · Scientific Reports · doi:10.1038/srep42604 · Cited by 51
Metabolic reprogramming of mitochondrial respiration in metastatic cancer
Herst, P. M., Grasso, C., & Berridge, M. V. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9769-2 · Cited by 52
MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities
Bisso, A., Sabò, A., & Amati, B. B. (2019) · Immunological Reviews · doi:10.1111/imr.12734 · Cited by 57
Wei, G., Sun, J., Luan, W., Hou, Z., Wang, S., Cui, S., Cheng, M., & Liu, Y. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00644 · Cited by 51
Pan-cancer analysis of the metabolic reaction network
Gatto, F., Ferreira, R., & Nielsen, J. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.09.006 · Cited by 57
Targeting Cell Metabolism as Cancer Therapy
Ngoi, N. Y. L., Eu, J. Q., Hirpara, J. L., Wang, L., Lim, J. S. J., Lee, S. C., Lim, Y., Pervaiz, S., Goh, B. C., & Wong, A. L. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7947 · Cited by 60
“Asproposed in one theory, cancer cells are able to switch between glycolytic and OXPHOS modes, as they metamor-phose through different ‘‘waves’’ of metabolic regulation (34, 132).”
InfluentialLipogenic effects of androgen signaling in normal and malignant prostate
Mah, C. Y., Nassar, Z. D., Swinnen, J. V., & Butler, L. M. (2019) · Asian journal of urology · doi:10.1016/j.ajur.2019.12.003 · Cited by 61
“This provides proliferating cancer cells several advantages including (1) rapid and abundant ATP/energy production and (2) essential intermediates/ precursors needed for biosynthetic pathways [58,59].”
BackgroundOxidative Stress and Cancer Development: Are Noncoding RNAs the Missing Links?
D’Souza, L. C., Mishra, S., Chakraborty, A., Shekher, A., Sharma, A., & Gupta, S. C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7987 · Cited by 59
“However, evidence toward this hypothesis is currently limited (25).”
Kishimoto, S., Brender, J., Chandramouli, G. V. R., Saida, Y., Yamamoto, K., Mitchell, J. B., & Krishna, M. C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8131 · Cited by 50
“In addition, tumor cells often develop other altered chemical characteristics such as elevated aerobic glycolysis and low pH (9).”
Mammary epithelial cells have lineage-rooted metabolic identities
Mahendralingam, M. J., Kim, H., McCloskey, C. W., Aliar, K., Casey, A. E., Tharmapalan, P., Pellacani, D., Ignatchenko, V., García-Valero, M., Palomero, L., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00388-6 · Cited by 56
Karim, S., Burzangi, A. S., Ahmad, A., Siddiqui, N. A., Ibrahim, I. M., Sharma, P., Abualsunun, W. A., & Gabr, G. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042305 · Cited by 56
“Tumor cells are supported by metabolic rewiring in their growth, proliferation, survival, maintenance and reprogram the pathways of nutrient acquisition to meet the bioenergetics [1].”
BackgroundANGPTL4 regulate glutamine metabolism and fatty acid oxidation in nonsmall cell lung cancer cells
Song, X., Nai‐dong, W., Jin‐Xiang, Y., Long, T., Lu, X., Hong, G., Jie‐Cheng, Y., & Fei, Z. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16879 · Cited by 51
Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
de Wit, S., Glen, C., de Boer, R. A., & Lang, N. N. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac132 · Cited by 59
“Adjusted from DeBerardinis et al.(26) and Garcia-Ropero et al.”
BackgroundMethodUCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control
Luby, A., & Alves‐Guerra, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315077 · Cited by 58
“Thus, due to the dysregulated activation of oncogenes that induce the overexpression of glycolysis-stimulating enzymes, cancer cells oxidize abundant amounts of glucose [8].”
BackgroundCell biology-metabolic crosstalk in glioma
Colquhoun, A. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.022 · Cited by 51
Hexokinase 2 is dispensable for T cell-dependent immunity
Mehta, M., Weinberg, S. E., Steinert, E. M., Chhiba, K. D., Martinez, C. A., Gao, P., Perlman, H., Bryce, P. J., Hay, N., & Chandel, N. S. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0184-5 · Cited by 58
Self-citation
Metadata
- Authors
- DeBerardinis, R. J., & Chandel, N. S.
- Affiliations
- Children's Medical Center (US)
- Northwestern University (US)
- Corresponding author
- DeBerardinis, Ralph J.
- Chandel, Navdeep S.
- Venue
- Science Advances
- Published
- 2016-05-06
- Volume
- 2
- Issue
- 5
- Pages
- e1600200-e1600200
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4928883
- OpenAlex
- W2395626624
- Semantic Scholar
- bebecd5b21653ab07940aa17ec319c54e710f9dc
- Cited by
- 3,013
- References
- 204
- Citations by year
- 2026: 271 · 2025: 296 · 2024: 326 · 2023: 359 · 2022: 427 · 2021: 447 · 2020: 340 · 2019: 257 · 2018: 166 · 2017: 109 · 2016: 12
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ID0E1EAG7327, R01 CA123067)
- National Cancer Institute (ID0EAMAG7328, 5R01CA157996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, tumor bioenergetics, redox metabolism, nutrient acquisition, carcinogenesis, metastasis, cancer therapy
- MeSH terms
- Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Macromolecular Substances, Metabolic Networks and Pathways, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.